Ata uhi

QR Code

Oral bioavailability basic principles, advanced concepts, and applications /

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Kaituhi rangatōpū:	ebrary, Inc
Ētahi atu kaituhi:	Hu, Ming, Ph. D., Li, Xiaoling, 1957-
Hōputu:	Tāhiko īPukapuka
Reo:	Ingarihi
I whakaputaina:	Hoboken, NJ : John Wiley & Sons, c2011.
Rangatū:	Wiley series in drug discovery and development.
Ngā marau:	Drugs > Bioavailability. Drug development. Intestinal absorption. Electronic books.
Urunga tuihono:	An electronic book accessible through the World Wide Web; click to view
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Physiological pharmaceutics barriers to drug absorption /
mā: Washington, Neena, 1961-
I whakaputaina: (2001)

Absorption and drug development solubility, permeability, and charge state /
mā: Avdeef, Alex
I whakaputaina: (2012)

Caco-2 cells and their uses
I whakaputaina: (2011)

Formulation and analytical development for low-dose oral drug products
I whakaputaina: (2009)

Development of mammalian absorptive processes
I whakaputaina: (1979)

Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)

Biological drug products : development and strategies /
I whakaputaina: (2013)

Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)

Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)

Target validation in drug discovery
I whakaputaina: (2006)

Lead generation approaches in drug discovery
I whakaputaina: (2010)

Drug development principles, methodology and emerging challenges /
I whakaputaina: (2013)

In silico lead discovery
mā: Miteva, Maria A.
I whakaputaina: (2011)

Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
I whakaputaina: (2010)

Oral drug absorption
I whakaputaina: (2000)

The quest for the cures the science, stories and struggles behind the next generation of medicines /
mā: Stockwell, Brent R.
I whakaputaina: (2011)

Bioavailability of contaminants in soils and sediments processes, tools, and applications /
I whakaputaina: (2003)

A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)

A comprehensive guide to toxicology in preclinical drug development
I whakaputaina: (2013)

Introduction to biological and small molecule drug research and development theory and case studies /
I whakaputaina: (2013)

Analogue-based drug discovery III
I whakaputaina: (2013)

Global new drug development : an introduction /
mā: Rosier, Jan A., me ētahi atu.
I whakaputaina: (2014)

ADME-enabling technologies for drug design and development
I whakaputaina: (2012)

Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)

Peptide transport and hydrolysis
I whakaputaina: (1977)

Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)

Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)

Nonclinical safety assessment a guide to international pharmaceutical regulations /
I whakaputaina: (2013)

Data mining in drug discovery /
I whakaputaina: (2014)

Drug utilization research : methods and applications /
I whakaputaina: (2016)

Lead optimization for medicinal chemists pharmacokinetic properties of functional groups and organic compounds /
mā: Dörwald, Florencio Zaragoza
I whakaputaina: (2012)

Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)

Topical and transdermal drug delivery principles and practice /
I whakaputaina: (2011)

Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)

Drug metabolism prediction /
I whakaputaina: (2014)

Systems biology in drug discovery and development
I whakaputaina: (2011)

Early drug development strategies and routes to first-in-human trials /
I whakaputaina: (2010)

The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)

Molecular pathology in drug discovery and development
I whakaputaina: (2009)

Statistical issues in drug development
mā: Senn, Stephen
I whakaputaina: (2007)